Javascript must be enabled to continue!
Perio Protect™ Treatment of Chronic Periodontitis Reduces Biofilm and Inflammation
View through CrossRef
Periodontal health exists when a small numbers of predominantly Gram-positive aerobes, with fewer Gram-positive facilitative and a small number of obligate anaerobes live supragingival and subgingival in sulci less than 3 mm. The biofilm and host cohabitate in a commensal or mutualistic relationship without a host inflammatory response. Periodontal disease occurs when there is a shift in critical wound composition of the periodontal subgingival microbiome associated with host micro-environment changes. The oxygen saturation decreases, and an imbalance (dysbiosis) occurs where the more virulent anaerobic pathogenic microorganisms predominate at the expense of aerobic commensal microorganisms, fostering a chronic wound, resulting in an inflammatory immune response. Existing treatments focus on controlling plaque but fail to manage the immune inflammatory reaction. The Perio Protect Method™ manages plaque and inflammation through subgingival delivery of 1.7% hydrogen peroxide (Perio Gel™) and antioxidants. Perio Trays™ are FDA cleared medical devices manufactured with customized seals and extensions which compress the wound and overcome crevicular flow and deliver medications better than other dental appliances to the source of the dental infection. Perio Gel™ generates 5.3 X oxygen saturation in the Perio Tray™ comparable to the oxygen saturation in a hyperbaric chamber. Thr Perio Protect Method™ manages obligate anaerobes, accelerates tissue recovery, healing, and repair, establishes a microenvironment reversing dysbiosis, and improves systemic LpPLA2 and hs-CRP levels. The numbers of virulent facultative and obligate anaerobes decrease and are replaced with fewer aerobic bacteria found in healthy tissues. Anti-inflammatory medications neutralize the host inflammatory response, decrease tissue damages, and augment osteogenic improvements. Managing periodontal inflammation is medically important because emerging evidence demonstrates a strong relationship between periodontal inflammation and numerous systemic conditions including, but not limited to, atherosclerosis, stroke, Alzheimer’s disease, type 2 diabetes, obesity, and rheumatoid arthritis. A common link in these systemic conditions with periodontitis is an increased systemic inflammatory burden, which exacerbates other co-existing inflammatory conditions leading to related diseases. Treatments convert the microenvironment from disease to health (reverse dysbiosis) and address both the etiology (biofilm) and the inflammatory host responses. The Perio Protect Method™ is a treatment regimen that becomes a long-term periodontal homecare system.
Title: Perio Protect™ Treatment of Chronic Periodontitis Reduces Biofilm and Inflammation
Description:
Periodontal health exists when a small numbers of predominantly Gram-positive aerobes, with fewer Gram-positive facilitative and a small number of obligate anaerobes live supragingival and subgingival in sulci less than 3 mm.
The biofilm and host cohabitate in a commensal or mutualistic relationship without a host inflammatory response.
Periodontal disease occurs when there is a shift in critical wound composition of the periodontal subgingival microbiome associated with host micro-environment changes.
The oxygen saturation decreases, and an imbalance (dysbiosis) occurs where the more virulent anaerobic pathogenic microorganisms predominate at the expense of aerobic commensal microorganisms, fostering a chronic wound, resulting in an inflammatory immune response.
Existing treatments focus on controlling plaque but fail to manage the immune inflammatory reaction.
The Perio Protect Method™ manages plaque and inflammation through subgingival delivery of 1.
7% hydrogen peroxide (Perio Gel™) and antioxidants.
Perio Trays™ are FDA cleared medical devices manufactured with customized seals and extensions which compress the wound and overcome crevicular flow and deliver medications better than other dental appliances to the source of the dental infection.
Perio Gel™ generates 5.
3 X oxygen saturation in the Perio Tray™ comparable to the oxygen saturation in a hyperbaric chamber.
Thr Perio Protect Method™ manages obligate anaerobes, accelerates tissue recovery, healing, and repair, establishes a microenvironment reversing dysbiosis, and improves systemic LpPLA2 and hs-CRP levels.
The numbers of virulent facultative and obligate anaerobes decrease and are replaced with fewer aerobic bacteria found in healthy tissues.
Anti-inflammatory medications neutralize the host inflammatory response, decrease tissue damages, and augment osteogenic improvements.
Managing periodontal inflammation is medically important because emerging evidence demonstrates a strong relationship between periodontal inflammation and numerous systemic conditions including, but not limited to, atherosclerosis, stroke, Alzheimer’s disease, type 2 diabetes, obesity, and rheumatoid arthritis.
A common link in these systemic conditions with periodontitis is an increased systemic inflammatory burden, which exacerbates other co-existing inflammatory conditions leading to related diseases.
Treatments convert the microenvironment from disease to health (reverse dysbiosis) and address both the etiology (biofilm) and the inflammatory host responses.
The Perio Protect Method™ is a treatment regimen that becomes a long-term periodontal homecare system.
Related Results
Effect of CRP, IL-6, Leukocytes, NLR on Chronic Periodontitis in Acute Coronary Syndrome
Effect of CRP, IL-6, Leukocytes, NLR on Chronic Periodontitis in Acute Coronary Syndrome
Chronic periodontitis is associated with coronary heart disease (CHD), including Acute Coronary Syndrome (ACS), which causes inflammation. CRP, IL-6, leukocytes, neutrophils, and l...
Low salivary uric acid levels are independently associated with periodontitis
Low salivary uric acid levels are independently associated with periodontitis
BACKGROUND
Lower salivary uric acid concentrations, the most abundant antioxidant agent in saliva, have been observed in patients with periodontitis compared to individua...
High Salivary 3-Nitrotyrosine Levels in Periodontitis
High Salivary 3-Nitrotyrosine Levels in Periodontitis
Background: Tyrosine, a non-essential amino acid involved in protein biosynthesis, can undergo oxidative modification upon exposure to reactive species like the peroxynitrite radic...
Low salivary thioredoxin-1 levels in periodontitis
Low salivary thioredoxin-1 levels in periodontitis
BACKGROUND
The protein thioredoxin-1 (TRX-1) has anti-oxidative, anti-inflammatory and anti-apoptotic effects, and it has been related to the regulation of ageing...
Counterclockwise rotation of the flagellum promotes biofilm initiation in
Helicobacter pylori
Counterclockwise rotation of the flagellum promotes biofilm initiation in
Helicobacter pylori
ABSTRACT
Motility promotes biofilm initiation during the early steps of this process: microbial surface association and attachmen...
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
Optogenetic Modulation of a Productive Biofilm for Improved Biotransformation
<p>Biofilm as a living catalysts has been exploited for the production of biofuels and bioelectricity in microbial fuel cells (MFCs) as well as in the synthesis of bu...
Association Between Salivary Sirtuin-1 Levels and Periodontitis
Association Between Salivary Sirtuin-1 Levels and Periodontitis
Background: Sirtuin-1 (SIRT-1) is one enzyme that has anti-oxidative, anti-inflammation and anti-apoptosis effects, and it is involved in regulating aging and in different age-asso...
Periodontitis in young individuals - follow up of treatment and disease progression
Periodontitis in young individuals - follow up of treatment and disease progression
<p dir="ltr">Background and aims: Periodontitis in young individuals, though rare, is often characterized by early onset, rapid progression, and aggressive clinical presentat...

